CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,548

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Atrial FibrillationHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Interventions
DEVICE

CE-marked Catheter Ablation

Once patients have been randomized to the catheter ablation (CA) group, the ablation procedure must be performed within 4 weeks. CA will initially aim at pulmonary vein isolation.

Trial Locations (1)

13353

RECRUITING

Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin

Sponsors
All Listed Sponsors
collaborator

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

OTHER

collaborator

Kompetenznetz Vorhofflimmern e.V. (AFNET)

UNKNOWN

collaborator

Boston Scientific Corporation

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER

NCT05508256 - CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter